Merck's RSV Treatment Shows Promising Results in Latest Clinical Tri...

Highlights:,Positive Clinical Trial Results:,Merck's clesrovimab reduces RSV-related hospitalizations by over 84% in a mid-to-late-stage trial.,No Maj...

Despite a 28% Decline, Inspiration Healthcare Group plc (LON:IHC) Sh...

Highlights:,Inspiration Healthcare Group plc shares have declined by 28% in the past month, contributing to a significant 55% loss over the last twelv...

Oncimmune's Recapitalisation Efforts Lead to a 7% Gain in Share Pric...

Highlights:,Oncimmune Holdings PLC has experienced a 7% increase in share price following a successful fundraising initiative and debt restructuring.,...

Weight Loss Drugs Like Ozempic Could Curb Alcohol, Opioid Addiction

Highlights:,Study Findings,: GLP-1 drugs like Ozempic were linked to a 40% lower rate of opioid overdoses and a 50% reduction in alcohol intoxication...

A stock decline of 11% this week has led to a 78% loss for sharehold...

Highlights:,BATM Advanced Communications Ltd. has seen a dramatic 78% decline in share price over the past three years, raising concerns among shareho...

Avacta Group Expands Oncology Pipeline with Two Novel Preclinical As...

Highlights,Avacta has added two new preclinical oncology assets, AVA6103 and AVA7100, to its pipeline, utilizing its pre|CISION® technology.,AVA6103 t...

Feedback PLC Secures Key NHS Funding for Bleepa Platform, Shares Sur...

Highlights:,NHS Funding Boost,: Feedback’s Bleepa platform becomes eligible for reimbursement under the NHS Elective Recovery Fund.,Strategic Partners...

Image Scan Secures £3 Million Deal with NP Aerospace for Portable X-...

Highlights:,Major Contract Secured,: Image Scan Holdings signed a £3 million deal with NP Aerospace for its portable X-ray systems.,Long-term Revenue...

Graft Polymer Partners with University of Nottingham to Research New...

Key Points:,Graft Polymer and Awakn Life Sciences have partnered with the University of Nottingham to study the potential of an aminoindane new chemic...

IQ-AI is nearing an important milestone in its cancer treatment init...

Highlights:,IQ-AI Ltd is nearing completion of its Phase I clinical trial for the IB003 cancer treatment, with only two patients remaining to enroll.,...

Avacta Group Strengthens Leadership with Oncology Expert Michelle Mo...

Key Points,:,Dr. Michelle Morrow, an experienced oncology expert, has been appointed as Chief Scientific Officer at Avacta Group.,She brings nearly 20...

Lundbeck Acquires Longboard Pharmaceuticals in $2.6bn Deal to Bolste...

Highlights:,Strategic Acquisition,: Lundbeck will acquire Longboard Pharmaceuticals for $2.6 billion, strengthening its portfolio of treatments for ne...

Mendell Helium Sells Plant-Based Health and Wellness Business to Ors...

Highlights:,Strategic Sale,: Mendell Helium sells its plant-based health and wellness business to Orsus Therapeutics, retaining a 28% stake.,Helium Fo...

Oxford BioDynamics Faces Urgent Need for New Funding Amid Share Plun...

Highlights:,New Funding Needed,: Oxford BioDynamics announced that it requires additional funding by Q1 2025 to maintain operations.,Cost-Cutting Init...

Positive Outcomes in Phase III Nasal Polyps Study Highlighted by GSK

Highlights:,GSK PLC reports positive results from two phase III clinical trials (ANCHOR-1 and ANCHOR-2) for its treatment depemokimab targeting chroni...

Verici Dx Postpones ‘Tutivia’ Revenue as Medicare Approval Drags On

Highlights:,CMS Coverage Delay,: Verici Dx’s Tutivia test faces a delay in Medicare approval, pushing revenue recognition to 2025.,Financial Stability...

SkinBioTherapeutics Acquires Bio-Tech Solutions Ltd for £1.25 Millio...

Highlights,SkinBioTherapeutics has acquired Bio-Tech Solutions Ltd for £1.25 million.,The deal will be financed through a combination of a £950,000 lo...

ProBiotix Health Enters New Partnership with Mexico-Based Raff

Key Points:,Strategic Partnership,: ProBiotix teams up with Raff, a key player in the Mexican dairy and nutraceutical sectors.,Market Potential,: Mexi...

Avacta Group Presents Breakthrough Preclinical Data on Pre|CISION™ P...

Key Points:,AVA6103,, a new peptide drug conjugate (PDC), targets Topoisomerase I inhibitors to tumor cells, reducing toxicity to healthy tissues and...

GSK Reaches $2.2bn Settlement in Zantac Litigation in the United Sta...

Highlights:,GSK PLC has agreed to pay up to $2.2 billion to settle approximately 80,000 US lawsuits related to its heartburn medication, Zantac.,The s...